HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 57 filers reported holding HOMOLOGY MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371 | +18450.0% | 317 | -86.7% | 0.00% | – |
| Q1 2023 | $2 | -91.3% | 2,387 | -86.7% | 0.00% | -100.0% |
| Q4 2022 | $23 | -99.8% | 17,938 | +193.9% | 0.00% | – |
| Q3 2022 | $10,000 | -28.6% | 6,103 | -12.4% | 0.00% | – |
| Q2 2022 | $14,000 | +40.0% | 6,965 | +111.6% | 0.00% | – |
| Q1 2022 | $10,000 | -89.6% | 3,292 | -87.6% | 0.00% | -100.0% |
| Q4 2021 | $96,000 | +1100.0% | 26,531 | +2275.2% | 0.00% | – |
| Q3 2021 | $8,000 | -66.7% | 1,117 | -66.7% | 0.00% | -100.0% |
| Q2 2021 | $24,000 | -25.0% | 3,356 | +0.7% | 0.00% | 0.0% |
| Q1 2021 | $32,000 | -22.0% | 3,333 | -8.1% | 0.00% | 0.0% |
| Q4 2020 | $41,000 | -86.1% | 3,626 | -86.9% | 0.00% | -66.7% |
| Q3 2020 | $296,000 | +98.7% | 27,583 | +181.3% | 0.00% | -50.0% |
| Q2 2020 | $149,000 | +115.9% | 9,805 | +195.3% | 0.01% | 0.0% |
| Q4 2019 | $69,000 | +475.0% | 3,320 | +404.6% | 0.01% | +500.0% |
| Q3 2019 | $12,000 | -14.3% | 658 | +34.8% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | – | 488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $51,211,000 | 17.25% |
| Vida Ventures Advisors, LLC | 770,845 | $8,703,000 | 1.79% |
| AAF Wealth Management, LLC | 59,790 | $675,000 | 0.61% |
| Vivo Capital, LLC | 853,143 | $9,632,000 | 0.43% |
| Bellevue Group AG | 1,737,122 | $19,612,000 | 0.22% |
| PREMIER ASSET MANAGEMENT LLC | 77,108 | $871,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $36,357,000 | 0.16% |
| American Investment Services, Inc. | 36,955 | $417,000 | 0.13% |
| Virtus ETF Advisers LLC | 24,646 | $278,000 | 0.12% |
| FIRST MIDWEST BANK TRUST DIVISION | 65,983 | $745,000 | 0.11% |